MoneyWorks4Me

Biocon informs about press release

18 Dec 2023 Evaluate

Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Concludes Integration of Acquired Biosimilars Business in 120 countries; 10+ Emerging Markets, Japan & ANZ Transition in Final Phase'. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1792.25
Dr. Reddys Labs. 1200.50
Cipla 1332.40
Lupin 2010.95
Zydus Lifesciences 1131.60
View more..